Answers are grounded in this paper and cite their sources.
High-dose propofol infusion for sedation of patients in the intensive care unit can result in rhabdomyolysis, acute renal failure, metabolic acidosis, hyperkalemia, ventricular arrhythmia, hyperthermia, and death. The death of a patient with such complications after lung biopsy is reported. Until a safer dosage range has been determined, propofol infusion at rates higher than 5 mg x kg(-1) x h(-1) should be discouraged for long-term sedation (> 48 h).
No takes yet. Share an insight, caveat, or question.
Suen et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: